dr. jones on the efficacy of venetoclax in relapsed/refractory cll
Published 7 years ago • 514 plays • Length 2:16Download video MP4
Download video MP3
Similar videos
-
1:31
dr. jeffrey jones on the efficacy of venetoclax in treatment for cll
-
1:13
dr. jones on the safety of venetoclax in cll
-
1:27
dr. jones on studying venetoclax in r/r cll
-
1:47
dr. jeffrey jones on efficacy of idelalisib/ofatumumab combination in cll
-
2:12
dr. brander on the safety and efficacy of ibrutinib/venetoclax in cll
-
1:46
treating relapsed/refractory cll with venetoclax
-
24:09
update on venetoclax for cll
-
1:28
the benefits of venetoclax in cll
-
6:42
venetoclax rituximab in relapsed cll
-
2:27
dr fürstenau on the efficacy of frontline venetoclax-based combinations in cll
-
1:36
dr. shadman on the efficacy of venetoclax in cll
-
2:09
phase ii trial of venetoclax monotherapy for relapsed/refractory cll with 17p deletion
-
1:51
the safety and efficacy of retreatment with venetoclax plus rituximab in r/r cll
-
1:16
dr. wierda on ibrutinib plus venetoclax in cll
-
3:33
investigating the safety and efficacy of re-treating cll patients with venetoclax-based regimens
-
1:29
dr. james on update of ibrutinib for chronic lymphocytic leukemia
-
3:43
cll: clinical data for rituximab/venetoclax
-
1:33
dr. jeffrey jones on nccn recommendations for relapsed patients with cll
-
1:06
safety analysis of the bcl-2 inhibitor venetoclax for cll